KAITLIN ROGGE: Open Payments
NPI 1063196707 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 22 payments from 18 companies in 2025. Trend: 2023 $82 · 2024 $357 · 2025 $769
Food & beverage: $679Education: $90
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $156 |
| Boston Scientific Corporation | 1 | $143 |
| Actelion Pharmaceuticals US, Inc. | 2 | $104 |
| ABBVIE INC. | 1 | $70 |
| Astellas Pharma US Inc | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Novo Nordisk Inc | 1 | $30 |
| Dexcom, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Korlym, OverStitch NXT Endoscopic Suturing System, OPSUMIT, UBRELVY, Veozah, GARDASIL 9, Ozempic, Dexcom G6 Transmitter.
Industry payments across NE — which companies pay providers there.
